Skip to Main Content

Advertisement

Skip Nav Destination

CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo

J Exp Med (2015) 212 (8): 1171–1183.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal